Abstract Number: 1361 • 2014 ACR/ARHP Annual Meeting
Rheumatologists’ Attitudes on Cardiovascular Risk and Lipid Screening in Patients with Rheumatoid Arthritis at an Academic Medical Center
Background/Purpose: Cardiovascular (CV) disease is a major cause of morbidity and mortality in the rheumatoid arthritis (RA) population. Thus, the recognition and management of cardiovascular…Abstract Number: 1360 • 2014 ACR/ARHP Annual Meeting
Monitoring Methotrexate and Leflunomide Treatment for Liver Toxicity: the Kaiser Permanente Experience
Background/Purpose: Methotrexate (MTX) and Leflunomide (LEF) are widely prescribed to treat rheumatologic and other diseases. Each has the potential to cause liver injury in some…Abstract Number: 1358 • 2014 ACR/ARHP Annual Meeting
A Systematic Analysis of the Safety of Prescribing Anti-Rheumatic Immunosuppressive and Biologic Drugs in Pregnant Women
Background/Purpose The use of anti-rheumatic drugs in pregnancy is often complicated by concerns over their potential for adverse effects. Given that rheumatic diseases often affect…Abstract Number: 1359 • 2014 ACR/ARHP Annual Meeting
Care of Women with Rheumatological Conditions during Family Planning and Pregnancy
Background/Purpose Rheumatological diseases often affect women of reproductive age and can impact pregnancy outcomes. There is a need to understand how patients (pts) are managed…Abstract Number: 1329 • 2014 ACR/ARHP Annual Meeting
Comparison of Clinical and Serological Features of Childhood Sjögren Syndrome Based on the Presence or Absence of Parotitis
Background/Purpose: Sjögren syndrome is a complex autoimmune disease that affects lacrimal and salivary glands with the potential to cause damage to other organs. Diagnosis of…Abstract Number: 1328 • 2014 ACR/ARHP Annual Meeting
Modulation of Natural IgM-Autoantibodies to Oxidative Stress-Related Neo-Epitopes on Apoptotic Cells in Newborns of Mothers with Anti-Ro Autoimmunity
Background/Purpose At birth, the human immune system expresses substantial circulating levels of polymeric IgM that include autoantibodies to oxidation-associated epitopes on apoptotic cells. This study…Abstract Number: 1327 • 2014 ACR/ARHP Annual Meeting
Decreased CD3-CD16CD56+ Natural Killer Cell Counts Are Associated with Disease Activity in Children with Orbital Myositis
Background/Purpose: Orbital myositis (OM), an inflammatory disease affecting the extra-ocular muscles, typically presents in the third decade. It more commonly affects females and is extremely…Abstract Number: 1326 • 2014 ACR/ARHP Annual Meeting
Transition of Care and Long-Term Outcomes of Juvenile Systemic Sclerosis during Adulthood: Results from a French Single-Center Case-Control Study
Background/Purpose To describe the transition of care from Pediatric to an adult Internal Medicine department and long-term outcomes of patients with juvenile-onset SSc. Methods Twenty…Abstract Number: 1325 • 2014 ACR/ARHP Annual Meeting
Single Hub and Access Point for Pediatric Rheumatology in Europe (SHARE): Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Localized Scleroderma and Juvenile Systemic Sclerosis
Background/Purpose Juvenile Localized Scleroderma (JLS) and Juvenile Systemic Sclerosis (JSSc) form a group of rare pediatric diseases that can lead to significant morbidity. Evidence-based guidelines…Abstract Number: 1324 • 2014 ACR/ARHP Annual Meeting
Predictors of Disease Relapse in Juvenile Localized Scleroderma
Background/Purpose Localized scleroderma (LS) is an autoimmune disease characterized by inflammation of the skin and underlying tissue leading tissue damage including atrophy, dyspigmentation, and fibrosis. …Abstract Number: 1323 • 2014 ACR/ARHP Annual Meeting
Gastrointestinal Involvement in Juvenile Systemic Sclerosis: Development of Recommendations for Screening and Investigation
Background/Purpose There are currently no agreed recommendations on how to investigate children for gastrointestinal (GI) involvement in Juvenile Systemic Sclerosis (JSSc). The aim of screening…Abstract Number: 1322 • 2014 ACR/ARHP Annual Meeting
Cardiopulmonary Involvement in Juvenile Systemic Sclerosis: Development of Recommendations for Screening and Investigation
Background/Purpose There are currently no agreed recommendations on how to investigate children for cardiopulmonary involvement in Juvenile Systemic Sclerosis (JSSc). The aim of screening is…Abstract Number: 1340 • 2014 ACR/ARHP Annual Meeting
Choosing Subserologies Wisely: An Opportunity for Rheumatologic Healthcare Resource Savings
Background/Purpose: In March 2013, the American College of Rheumatology published its Top 5 List of Things Physicians and Patients Should Question as part of the…Abstract Number: 1341 • 2014 ACR/ARHP Annual Meeting
Choosing Not so Wisely: The Tale of Antinuclear Antibody Testing
Background/Purpose Choosing Wisely campaign aims to promote evidence based care that is truly necessary and not duplicative. ACR has furnished guidelines for use of ANA…Abstract Number: 1339 • 2014 ACR/ARHP Annual Meeting
Is Psychological Status Related to Symptom Experience in Behçet’s Syndrome?
Background/Purpose Little is known about the impact of Behçet’s Syndrome (BS) within the UK. The recent establishment of National Centres of Excellence now allows a…
ACR Meeting Abstracts